Peer Review reports
From: Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
| Original Submission | ||
|---|---|---|
| 29 Sep 2017 | Submitted | Original manuscript |
| 12 Oct 2017 | Author responded | Author comments - Brian Khong |
| Resubmission - Version 2 | ||
| 12 Oct 2017 | Submitted | Manuscript version 2 |
| 25 Oct 2017 | Author responded | Author comments - Brian Khong |
| Resubmission - Version 3 | ||
| 25 Oct 2017 | Submitted | Manuscript version 3 |
| 20 Dec 2017 | Reviewed | Reviewer Report - Kishore Challagundla |
| 22 Dec 2017 | Reviewed | Reviewer Report - Deepkamal Karelia |
| 16 Aug 2018 | Reviewed | Reviewer Report - Luigia stefania Stucci |
| 28 Aug 2018 | Author responded | Author comments - Brian Khong |
| Resubmission - Version 4 | ||
| 28 Aug 2018 | Submitted | Manuscript version 4 |
| Publishing | ||
| 12 Sep 2018 | Editorially accepted | |
| 20 Oct 2018 | Article published | 10.1186/s12885-018-4810-y |
You can find further information about peer review here.